Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.

Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review. Ital J Pediatr (2016) 0.75

Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics (2002) 12.32

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99

The LMS method for constructing normalized growth standards. Eur J Clin Nutr (1990) 6.89

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93

Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab (2010) 2.29

Wnt signaling in myogenesis. Trends Cell Biol (2012) 1.79

Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab (2010) 1.66

Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet (2005) 1.52

Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis. J Musculoskelet Neuronal Interact (2009) 1.37

Osteoporosis-pseudoglioma syndrome. Am J Med Genet (1993) 1.00

Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone (2012) 0.98

Heparan sulfate 6-O-endosulfatases (Sulfs) coordinate the Wnt signaling pathways to regulate myoblast fusion during skeletal muscle regeneration. J Biol Chem (2012) 0.96

Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab (2012) 0.96

Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates. Bone (2008) 0.95

Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis. Mol Neurobiol (2013) 0.92

Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab (2013) 0.92

Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma. J Bone Miner Res (2011) 0.92

Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. Horm Res Paediatr (2012) 0.90

Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG). J Pediatr Endocrinol Metab (2006) 0.88

Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5. J Bone Miner Res (2015) 0.87

Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation. J Pediatr Endocrinol Metab (2008) 0.86